Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486)

Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486) is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486) have?

Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486) has 48 citations in the OpenAlex counts ScholarIQ stores.

When was Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486) published?

Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486) has 2006 year in the ScholarIQ index.

What is the open-access status of Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486)?

Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486) has closed oa status in the ScholarIQ index.

What is the DOI of Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486)?

The DOI for Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486) is on the source record.

What is the PMID of Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486)?

The PMID for Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486) is on the source record.

What is the OpenAlex record for Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486)?

The OpenAlex for Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486) is on the source record.